Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) has been given a consensus rating of “Hold” by the nine ratings firms that are covering the firm, reports Marketbeat.com. One equity research analyst has rated the stock with a sell recommendation, four
Clinton Hill Manse With Garage Asks $6.5 Million
This corner manse has a fair number of the design hallmarks associated with Brooklyn architect Montrose Morris, and its lush details have apparently been appreciated by location scouts as it has some film and tv credits on its resume, according

